In an expert interview filmed at AAO 2018, Dr Deepinder Dhaliwal discusses the difference between Descemet membrane endothelial keratoplasty (DMEK) and descemetorhexis without endothelial keratoplasty (DWEK) for the treatment of Fuchs’ dystrophy. Dr Dhaliwal explains that in her recent study, corneal oedema was shown to clear on its own, in approximately 7 weeks, after a 4 mm descemetorhexis centred on the visual axis. She also describes that although patients may experience faster results in, terms of vision improvement, with DMEK, this procedure may incur more post-operative complications, such as increased intraocular pressure, when compared to DWEK.
In part 2 of her interview, Dr Deepinder Dhaliwal describes which patients make ideal candidates for descemetorhexis without endothelial keratoplasty (DWEK), and those that are contraindicated. Dr Dhaliwal also explains why some studies may have reported poor outcomes with DWEK. Reasons such as failure to provide rho kinase inhibitors as part of the post-operative management, or those with advanced corneal disease.
1. What are the limitations of the use of Descemet membrane endothelial keratoplasty (DMEK) for patients with Fuchs’ endothelial corneal dystrophy? (0:11)
2. What is the rationale for the use of descemetorhexis without endothelial keratoplasty (DWEK)? (0:50)
3. What were the findings of your recent study comparing the two treatment modalities? (1:47)
4. Which patients are best suited to treatment with descemetorhexis without endothelial keratoplasty (DWEK) and what are the contraindications? (0:11)
5. Why have some studies reported poor outcomes for DWEK? (1:05)
Speaker disclosures: Deepinder Dhaliwal has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Corneal Disorders
Ana Mercedes García-Albisua, ASCRS 2022: Bowman Layer Transplantation Using a Femtosecond Laser for Keratoconus
Keratoconus is characterized by the thinning of the cornea and irregularities of the cornea’s surface. In this touchOPHTHALMOLOGY interview with Dr Ana Mercedes García-Albisua (Hospital “Luis Sánchez Bulnes”, México City, México), a variation of the original manual Bowman layer transplantation technique is described. After the isolation of the graft, a stromal pocket is created using […]
Ana Mercedes García-Albisua, ASCRS 2022: Bowman Layer Transplantation Using a Femtosecond Laser: 3 Years Results
The aims, design and findings of the retrospective study evaluating the 3-year clinical outcomes of isolated Bowman layer transplantation using femtosecond laser as a treatment for patients with progressive keratoconus is discussed in this touchOPHTHALMOLOGY interview with Dr Ana Mercedes García-Albisua (Hospital “Luis Sánchez Bulnes”, México City, México) as well as how possible complications of […]
Paula Sepulveda-Beltran, ASCRS 2022: Clinical and Surgical Outcomes of Keratoplasty in Individuals That Received Rose Bengal Photodynamic Antimicrobial Therapy
The long-term clinical outcomes of Rose Bengal Photodynamic Antimicrobial Therapy (RB-PDAT) for infectious keratitis and the surgical outcomes of individuals that underwent keratoplasty after RB-PDAT is discussed in this touchOPHTHALMOLOGY interview with Dr Paula Sepulveda-Beltran (Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL). RB-PDAT is a potential adjunct therapy for infectious […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!